Clinical Trials Browser

Phase 2/3 × Recruiting × Androgen Antagonists × Clear all

NCT06861192 2025-11-18

Clinical Study of Fasudil Hydrochloride and PD1 Inhibitor Combined With Androgen Deprivation in Neoadjuvant Therapy of Prostate Cancer

Phase 2/3 Recruiting

Prostate CA

NCT06972511 2025-05-15

Maximal Tumor Eradication for Oligometastatic Prostate Cancer

Phase 2/3 Recruiting

Oligometastatic Prostate Cancer